Exercising with a Chest Infection: Why Rest Is Essential

Strenuous exercise during an acute chest infection (bronchitis, pneumonia, influenza, COVID-19) is contraindicated. It increases morbidity risk and delays recovery.

Physiological Risks

• Increased Cardiopulmonary Demand: Exercise raises O₂ consumption and CO₂ production. Inflamed, fluid-filled alveoli impair gas exchange → hypoxemia, hypercapnia.
• Myocarditis Risk: Viral infections (coxsackie, influenza, SARS-CoV-2) can involve myocardium. Exercise during active myocarditis increases risk of arrhythmia, sudden cardiac death, chronic cardiomyopathy. Guideline: No exercise until 2–4 weeks after symptom resolution + normal troponin/ECG/echo if cardiac symptoms.
• Airway Hyperreactivity: Bronchospasm worsened by cold/dry air inhalation during exertion.
• Immune Diversion: Intense exercise transiently suppresses mucosal immunity (IgA, NK cells) and redirects resources from pathogen clearance.

Transmission Risk

Respiratory droplets/aerosols spread efficiently during heavy breathing in close contact (team sports, gyms). Isolation until afebrile ×24 hrs and improving symptoms is standard.

Recovery Timeline

• Acute Phase (fever, severe cough, fatigue): Complete rest. ADLs only.
• Subacute (symptoms improving, no fever): Light activity (walking, gentle stretching) if no dyspnea at rest. Monitor HR/RPE.
• Return to Sport: Graduated return-to-play protocol (e.g., 50% → 75% → 100% over 7–14 days) after full symptom resolution. Medical clearance if hospitalized, cardiac symptoms, or prolonged illness.

When to Seek Care

• Dyspnea at rest, chest pain, palpitations, syncope, hemoptysis, persistent fever >3 days.
• Worsening after initial improvement (secondary bacterial pneumonia).

"Sweating it out" is a myth. Rest is the most evidence-based intervention for acute respiratory infection.